Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Thioperamide is a histamine H3 receptor antagonist (Ki = 4.3 nM).1 It is selective for the histamine H3 receptor over histamine H1 and H2 receptors (Kis = >10,000 nM for both) and a panel of 36 other receptors and ion channels. Thioperamide inhibits amygdaloid-kindled seizures (ED50 = 3.43 mg/kg) and reverses antinociception induced by the histamine H3 receptor agonist immepip (Item No. 29518) in rats.2,3 Thioperamide increases the time spent awake and decreases the time spent in deep slow wave sleep in rats.4 It decreases cognitive impairments in the APP/PS1 transgenic mouse model of Alzheimer’s disease.5
WARNING This product is not for human or veterinary use.
1. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-
2. Inhibitory effect of iodophenpropit, a selective histamine H3 antagonist, on amygdaloid kindled seizures. Brain Res. Bull. 63(2), 143-146 (2004).
3. Activation of peripheral and spinal histamine H3 receptors inhibits formalin-
4. Histamine H3 receptor antagonists: From target identification to drug leads. Biochem. Pharmacol. 73(8), 1084-1096 (2007).
5. Thioperamide attenuates neuroinflammation and cognitive impairments in Alzheimer’s disease via inhibiting gliosis. Exp. Neurol. 347, 113870 (2022).